Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Silvan Tuerkcan is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/18/2024 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 145.33% | $24 → $21 | Maintains | Market Outperform | Get Alert |
| 07/15/2024 | ELEV | Buy Now | Elevation Oncology | $2.64 | 165.15% | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/28/2024 | ELEV | Buy Now | Elevation Oncology | $2.64 | 165.15% | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/20/2024 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 133.64% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/31/2024 | CLLS | Buy Now | Cellectis | $2.23 | 169.06% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/13/2024 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $4.93 | 224.54% | $22 → $16 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 54.54% | → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/06/2024 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 180.37% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/30/2024 | TERN | Buy Now | Terns Pharma | $8.47 | 77.1% | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/25/2024 | ACRV | Buy Now | Acrivon Therapeutics | $7.33 | 131.92% | $14 → $17 | Maintains | Market Outperform | Get Alert |
| 04/22/2024 | BNTC | Buy Now | Benitec Biopharma | $10.59 | 51.09% | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 04/15/2024 | NTBL | Buy Now | Notable Labs | $0.72 | 1150% | → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/10/2024 | EXEL | Buy Now | Exelixis | $22.60 | 19.47% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/04/2024 | MGNX | Buy Now | Macrogenics | $4.93 | — | — | Reiterates | → Market Outperform | Get Alert |
| 04/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $7.33 | 91% | → $14 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/22/2024 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/20/2024 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 133.64% | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/18/2024 | TERN | Buy Now | Terns Pharma | $8.47 | 77.1% | $17 → $15 | Maintains | Outperform | Get Alert |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $4.93 | 346.25% | $16 → $22 | Maintains | Outperform | Get Alert |
| 03/07/2024 | ELEV | Buy Now | Elevation Oncology | $2.64 | 165.15% | → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/05/2024 | MNDY | Buy Now | Monday.Com | $219.83 | 27.37% | $240 → $280 | Maintains | Buy | Get Alert |
| 03/01/2024 | ELEV | Buy Now | Elevation Oncology | $2.64 | 165.15% | → $7 | Initiates | → Market Outperform | Get Alert |
| 03/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $7.33 | 91% | → $14 | Initiates | → Market Outperform | Get Alert |
| 02/15/2024 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -5.57% | $8 → $10 | Maintains | Market Outperform | Get Alert |
| 01/24/2024 | MGNX | Buy Now | Macrogenics | $4.93 | 224.54% | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 01/24/2024 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -24.46% | $6 → $8 | Maintains | Market Outperform | Get Alert |
| 12/19/2023 | NTBL | Buy Now | Notable Labs | $0.72 | 1150% | $13 → $9 | Maintains | Market Outperform | Get Alert |
| 12/14/2023 | EXEL | Buy Now | Exelixis | $22.60 | 19.47% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/11/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 43.76% | $74 → $80 | Maintains | Market Outperform | Get Alert |
| 12/05/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/05/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 32.97% | → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/13/2023 | EXEL | Buy Now | Exelixis | $22.60 | 19.47% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/01/2023 | CLLS | Buy Now | Cellectis | $2.23 | 169.06% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/23/2023 | GBIO | Buy Now | Generation Bio | $2.88 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/18/2023 | NTBL | Buy Now | Notable Labs | $0.72 | 1705.56% | → $13 | Initiates | → Market Outperform | Get Alert |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/06/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $58 → $82 | Maintains | Market Outperform | Get Alert |
| 10/04/2023 | MNDY | Buy Now | Monday.Com | $219.83 | 9.17% | $210 → $240 | Maintains | Buy | Get Alert |
| 09/28/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $58 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/26/2023 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -43.34% | $4 → $6 | Maintains | Market Outperform | Get Alert |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $22.60 | 19.47% | $24 → $27 | Maintains | Outperform | Get Alert |
| 08/15/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 86.92% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/14/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/07/2023 | CLLS | Buy Now | Cellectis | $2.23 | 169.06% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | EXEL | Buy Now | Exelixis | $22.60 | 6.19% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/26/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/25/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 32.97% | → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/19/2023 | EXEL | Buy Now | Exelixis | $22.60 | 6.19% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/30/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/26/2023 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -62.23% | → $68 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/16/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 32.97% | $70 → $74 | Maintains | Market Outperform | Get Alert |
| 05/18/2023 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -62.23% | $68 → $68 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | $17 → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/11/2023 | MGNX | Buy Now | Macrogenics | $4.93 | 102.84% | $8 → $10 | Maintains | Market Outperform | Get Alert |
| 05/10/2023 | EXEL | Buy Now | Exelixis | $22.60 | 6.19% | → $24 | Reiterates | → Market Outperform | Get Alert |
| 05/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 25.79% | → $70 | Reiterates | → Market Outperform | Get Alert |
| 05/05/2023 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 180.37% | $28 → $24 | Maintains | Market Outperform | Get Alert |
| 04/27/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | → Market Outperform | Get Alert |
| 04/21/2023 | MNDY | Buy Now | Monday.Com | $219.83 | -4.47% | $200 → $210 | Maintains | Buy | Get Alert |
| 04/19/2023 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 227.1% | → $28 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 25.79% | → $70 | Reiterates | → Market Outperform | Get Alert |
| 03/30/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 86.92% | → $4 | Reiterates | → Market Outperform | Get Alert |
| 03/29/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | → $17 | Reiterates | → Market Outperform | Get Alert |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | → $12 | Reiterates | → Market Outperform | Get Alert |
| 03/24/2023 | GBIO | Buy Now | Generation Bio | $2.88 | 143.06% | → $7 | Reiterates | → Market Outperform | Get Alert |
| 03/16/2023 | MGNX | Buy Now | Macrogenics | $4.93 | 62.27% | → $8 | Reiterates | → Market Outperform | Get Alert |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $2.23 | 169.06% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 03/06/2023 | GBIO | Buy Now | Generation Bio | $2.88 | -22.57% | $7 → $2.23 | Maintains | Market Outperform | Get Alert |
| 02/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 25.79% | → $70 | Reiterates | → Market Outperform | Get Alert |
| 02/14/2023 | TERN | Buy Now | Terns Pharma | $8.47 | 100.71% | → $17 | Initiates | → Market Outperform | Get Alert |
| 02/13/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | → $12 | Reiterates | → Market Outperform | Get Alert |
| 02/01/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 86.92% | $6 → $4 | Maintains | Market Outperform | Get Alert |
| 01/26/2023 | TWO | Buy Now | Two Harbors Inv | $13.75 | 30.91% | $17.5 → $18 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | VOR | Buy Now | Vor Biopharma | $0.91 | 1218.39% | $15 → $12 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 180.37% | $20 → $6 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 227.1% | $38 → $28 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | MGNX | Buy Now | Macrogenics | $4.93 | 62.27% | $18 → $8 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | GBIO | Buy Now | Generation Bio | $2.88 | 143.06% | $11 → $7 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | EXEL | Buy Now | Exelixis | $22.60 | 6.19% | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 25.79% | $100 → $70 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | CLLS | Buy Now | Cellectis | $2.23 | 169.06% | $11 → $6 | Maintains | Market Outperform | Get Alert |
| 01/19/2023 | NTLA | Buy Now | Intellia Therapeutics | $25.30 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/09/2022 | EXEL | Buy Now | Exelixis | $22.60 | 10.62% | $26 → $25 | Maintains | Market Outperform | Get Alert |
| 11/10/2022 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 834.58% | $22 → $20 | Maintains | Market Outperform | Get Alert |
| 10/18/2022 | BNTC | Buy Now | Benitec Biopharma | $10.59 | -62.23% | → $68 | Initiates | → Market Outperform | Get Alert |
| 10/18/2022 | EXEL | Buy Now | Exelixis | $22.60 | 15.04% | → $26 | Initiates | → Market Outperform | Get Alert |
| 09/19/2022 | NTLA | Buy Now | Intellia Therapeutics | $25.30 | 338.74% | $106 → $111 | Maintains | Market Outperform | Get Alert |
| 09/14/2022 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 343.93% | $35 → $38 | Maintains | Market Outperform | Get Alert |
| 08/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $90 → $110 | Maintains | Market Outperform | Get Alert |
| 08/08/2022 | GBIO | Buy Now | Generation Bio | $2.88 | 281.94% | $10 → $11 | Maintains | Market Outperform | Get Alert |
| 07/12/2022 | MGNX | Buy Now | Macrogenics | $4.93 | 305.68% | $24 → $20 | Maintains | Market Outperform | Get Alert |
| 06/07/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $72 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 05/13/2022 | VOR | Buy Now | Vor Biopharma | $0.91 | 1547.99% | $30 → $15 | Maintains | Market Outperform | Get Alert |
| 05/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $55.65 | 79.69% | $150 → $100 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | LOGC | Buy Now | LogicBio Therapeutics | $6.05 | -50.41% | $2 → $3 | Maintains | Market Outperform | Get Alert |
| 05/09/2022 | RLAY | Buy Now | Relay Therapeutics | $8.56 | 308.88% | $50 → $35 | Maintains | Market Outperform | Get Alert |
| 05/09/2022 | NTLA | Buy Now | Intellia Therapeutics | $25.30 | 334.78% | $165 → $110 | Maintains | Market Outperform | Get Alert |
| 04/01/2022 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 1582.24% | $44 → $36 | Maintains | Market Outperform | Get Alert |
| 03/16/2022 | VOR | Buy Now | Vor Biopharma | $0.91 | 3195.98% | $40 → $30 | Maintains | Market Outperform | Get Alert |
| 01/07/2022 | NTLA | Buy Now | Intellia Therapeutics | $25.30 | 552.17% | $175 → $165 | Maintains | Market Outperform | Get Alert |
| 12/15/2021 | GBIO | Buy Now | Generation Bio | $2.88 | 247.22% | — | Maintains | Market Outperform | Get Alert |
| 11/30/2021 | CLLS | Buy Now | Cellectis | $2.23 | 796.86% | — | Initiates | → Market Outperform | Get Alert |
| 11/16/2021 | LOGC | Buy Now | LogicBio Therapeutics | $6.05 | 164.46% | — | Maintains | Market Outperform | Get Alert |
| 11/11/2021 | TSHA | Buy Now | Taysha Gene Therapies | $2.14 | 1675.7% | — | Maintains | Market Outperform | Get Alert |
